VIROMED MEDICAL NA O.N. - Asset Resilience Ratio
VIROMED MEDICAL NA O.N. (VME) has an Asset Resilience Ratio of 0.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how VIROMED MEDICAL NA O.N.'s Asset Resilience Ratio has changed over time. See VME net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets Composition Over Time
This chart breaks down VIROMED MEDICAL NA O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is VIROMED MEDICAL NA O.N. worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €4.51K | 0.03% |
| Total Liquid Assets | €4.51K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: VIROMED MEDICAL NA O.N. maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
VIROMED MEDICAL NA O.N. Industry Peers by Asset Resilience Ratio
Compare VIROMED MEDICAL NA O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for VIROMED MEDICAL NA O.N. (2024–2025)
The table below shows the annual Asset Resilience Ratio data for VIROMED MEDICAL NA O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.03% | €4.51K ≈ $5.28K |
€13.91 Million ≈ $16.27 Million |
+0.00pp |
| 2024-12-31 | 0.03% | €3.78K ≈ $4.42K |
€13.40 Million ≈ $15.66 Million |
-- |
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.